NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Hepatocellular carcinoma (HCC) develops on the background of chronic hepatitis. Leukocytes found within the HCC microenvironment are implicated as regulators of tumour growth. We show that diethylnitrosamine (DEN)-induced murine HCC is attenuated by antibody-mediated depletion of hepatic neutrophils, the latter stimulating hepatocellular ROS and telomere DNA damage. We additionally report a previously unappreciated tumour suppressor function for hepatocellular nfkb1 operating via p50:p50 dimers and the co-repressor HDAC1. These anti-inflammatory proteins combine to transcriptionally repress hepatic expression of a S100A8/9, CXCL1 and CXCL2 neutrophil chemokine network. Loss of nfkb1 promotes ageing-associated chronic liver disease (CLD), characterized by steatosis, neutrophillia, fibrosis, hepatocyte telomere damage and HCC. Nfkb1 S340A/S340A mice carrying a mutation designed to selectively disrupt p50:p50:HDAC1 complexes are more susceptible to HCC; by contrast, mice lacking S100A9 express reduced neutrophil chemokines and are protected from HCC. Inhibiting neutrophil accumulation in CLD or targeting their tumour-promoting activities may offer therapeutic opportunities in HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and hepatocellular carcinoma (65).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [65]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased hepatocyte Snc burden is observed during aging and obesity in mice (15) and in chronic parenchymal liver disorders in humans such as chronic viral hepatitis (66), alcohol-related liver disease (65), NAFLD (15, 67), and genetic hemochromatosis (68).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [65]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Alcoholic liver disease and chronic viral hepatitis have also been associated with telomere dysfunction in human liver biopsies100,101.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [101]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Cellular senescence is implicated in the progression of liver disease.”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [65]
The cited source says what the claim attributes to it.
In the citing paper
“Additionally, the expression of CDKN1A, CDKN2A and the presence of TAF has been found in the context of non-alcoholic fatty liver disease159,161, and TAF have been reported in livers from individuals with alcoholic liver disease162.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [162]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
Knowledge‐based protein secondary structure assignment
Frishman, D., & Argos, P. (1995) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340230412 · Cited by 2,523
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
Self-citationNeutrophil Function: From Mechanisms to Disease
Amulic, B., Cazalet, C., Hayes, G. L., Metzler, K. D., & Zychlinsky, A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074942 · Cited by 1,708
Maeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Acharyya, S., Oskarsson, T., Vanharanta, S., Malladi, S., Kim, J., Morris, P. G., Manova-Todorova, K., Leversha, M., Hogg, N., Seshan, V. E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.042 · Cited by 1,085
Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice
Daley, J. M., Thomay, A. A., Connolly, M. D., Reichner, J. S., & Albina, J. E. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0407247 · Cited by 1,046
The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1
Zhong, H., May, M. J., Jimi, E., & Ghosh, S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00477-x · Cited by 939
Cited by
Items 101–171 of 171
Circular RNA hsa_circ_0062682 Binds to YBX1 and Promotes Oncogenesis in Hepatocellular Carcinoma
Razpotnik, R., Vidmar, R., Fonovič, M., Rozman, D., & Režen, T. (2022) · Cancers · doi:10.3390/cancers14184524 · Cited by 17
“On the other hand, NFκB1 was found to be a suppressor of a neutrophil-driven HCC [76].”
BackgroundEffects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver disease
Ochiai, Y., Kawamura, Y., Kobayashi, M., Shindoh, J., Kobayashi, Y., Okubo, S., Muraishi, N., Kajiwara, A., Iritani, S., Fujiyama, S., et al. (2020) · Hepatology Research · doi:10.1111/hepr.13572 · Cited by 16
Correction: Corrigendum: NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma
Wilson, C. L., Jurk, D., Fullard, N., Banks, P. S., Page, A., Luli, S., Elsharkawy, A. M., Gieling, R. G., Chakraborty, J. B., Fox, C. P., et al. (2015) · Nature Communications · doi:10.1038/ncomms9411 · Cited by 16
Self-citationXu, H., Wu, Z., Qin, J., Li, X., Xu, F., Wang, W., Zhang, H., Yin, H., Zhu, S., Zhang, W., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-334318 · Cited by 15
“41 42 These findings may indicate that LECT2 could regulate the expression of these two factors or that LECT2 and these pro-inflammatory chemokines may exert a synergistic effect in the pathogenesis in AH.”
Maturation of the Acute Hepatic TLR4/NF-κB Mediated Innate Immune Response Is p65 Dependent in Mice
Zárate, M. A., Nguyen, L., Dios, R. K. D., Zheng, L., & Wright, C. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01892 · Cited by 16
PI3Kγ promotes obesity-associated hepatocellular carcinoma by regulating metabolism and inflammation
Becattini, B., Breasson, L., Sardi, C., Zani, F., & Solinas, G. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100359 · Cited by 18
“Indeed, a study reported that in mice pups injected with DEN, neutrophils infiltrate into the liver and promote hepatocyte proliferation and HCC by exacerbating oxidative damage.(20) Consistently with this study, we observed reduced HCC number, hepatocyte proliferation, and liver neutrophil infiltration acutely induce…”
BackgroundInfluentialLin, S., Wen, J., Xu, X., Shi, J., Zhang, W., Zheng, T., Hou, Y., Zhang, Y., Li, Z., Wang, K., et al. (2022) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x22500586 · Cited by 18
A novel NFkB1 mutation linking pyoderma gangrenosum and common variable immunodeficiency
Sun, Q., Gehlhausen, J. R., Freudzon, M., Kibbi, N., Bale, A. E., Choate, K. A., Tomayko, M. M., Odell, I. D., & Ramachandran, S. M. (2021) · JAAD Case Reports · doi:10.1016/j.jdcr.2021.10.015 · Cited by 15
“Histopathology revealed dense neutrophilic infiltrates, and cultures for bacteria, fungi, and acid-fast bacilli were negative, altogether consistent with a diagnosis of PG. Treatment with prednisone 1 mg/kg/day resulted in clinical improvement, but after 1 week, the patient developed posterior reversible encephalopath…”
BackgroundInfluentialTelomere dysfunction in chronic liver disease: The link from aging
Penrice, D. D., Jalan‐Sakrikar, N., Jurk, D., Passos, J. F., & Simonetto, D. A. (2023) · Hepatology · doi:10.1097/hep.0000000000000426 · Cited by 17
“[122] Further studies to elucidate the role of telomere dysfunction in the development of ALD are needed, and should ideally explore whether baseline differences in telomere length and/or function exist between at risk heavy drinkers who do not develop liver disease and those that progress to AAH…”
Self-citationRole of altered immune cells in liver diseases: a review
Wahid, B., Ali, A., Rafique, S., Saleem, K., Waqar, M., Wasim, M., & Idrees, M. (2018) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2018.01.014 · Cited by 14
Huang, A., Wang, H., Wu, Z., Wang, Y.-H., Hu, B., Jiang, Z., Jin, M., Wang, L., & Gao, Y. (2019) · Translational Cancer Research · doi:10.21037/tcr.2019.09.54 · Cited by 15
“08 g/mL according to a previous study (18).”
MethodFan, M., Song, E., Zhang, Y., Zhang, P., Huang, B., Yan, K., Yang, W., Chakrabarti, S., Mahajan, H., Yan, S., et al. (2024) · Research · doi:10.34133/research.0382 · Cited by 17
“We first measured the number of CLSs that were positive for NE or PR3 by immunohistochemistry of liver sections in the discovery cohort (379 morbidly obese subjects, 122 [32.2”
InfluentialNoh, J., Kim, Y., Kim, D., Hwang, J. H., Kim, K., Choi, D., Lee, S., Lee, H. G., Lee, T. G., Weng, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33660-z · Cited by 14
Zaki, N. H. M., Shiota, J., Calder, A. N., Keeley, T. M., Allen, B. L., Nakao, K., Samuelson, L. C., & Razumilava, N. (2022) · Hepatology · doi:10.1002/hep.32492 · Cited by 13
Leslie, J., Robinson, S. M., Oakley, F., & Luli, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-81097-8 · Cited by 14
Self-citationCharacterization of chromatin accessibility in psoriasis
Zhang, Z., Liu, L., Shen, Y., Meng, Z., Chen, M., Lü, Z., & Zhang, X. (2021) · Frontiers of Medicine · doi:10.1007/s11684-021-0872-3 · Cited by 13
“The hepatic tissue NFKB1 transcriptionally represses CXCL2 expression [50].”
Backgroundc‐Rel–dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis
Leslie, J., Hunter, J. E., Collins, A., Rushton, A. J., Russell, L. G., Ramon‐Gil, E., Laszczewska, M., McCain, M. V., Zaki, M. Y. W., Knox, A., et al. (2022) · Hepatology · doi:10.1002/hep.32781 · Cited by 12
“[42] Mice lacking nfkb1 (p105/p50) spontaneously develop liver cancer with age[43] and have accelerated tumorigenesis in the DEN model[33] because of a loss of p50:p50 homodimers, which suppress hepatic inflammation and neutrophil recruitment.”
BackgroundMethodSelf-citationLi, Y., Du, X., & Mao, J. (2025) · International Journal of Oncology · doi:10.3892/ijo.2025.5766 · Cited by 15
“However, NF‑ κ B gene knockout can promote the occurrence of liver cancer (174).”
Transcriptomics Underlying Pulmonary Ozone Pathogenesis Regulated by Inflammatory Mediators in Mice
Cho, H., Jedlicka, A., Chang, F. H., Marzec, J. M., Bauer, A. K., & Kleeberger, S. R. (2021) · Antioxidants · doi:10.3390/antiox10091489 · Cited by 11
“The p50−p50 homodimer has thus been shown to have anti-inflammatory functions through repression of proinflammatory genes and enhancement of anti-inflammatory genes [48,49].”
BackgroundWang, Y.-F., Yang, Z., Feng, Y., Chen, H., Dai, S., Wang, Y., & Xu, M. (2023) · Molecules · doi:10.3390/molecules28093927 · Cited by 11
Repin1 deficiency in liver tissue alleviates NAFLD progression in mice
Abshagen, K., Mense, L., Fischer, F., Liebig, M., Schaeper, U., Navarro, G., Glass, A. S., Frank, M., Klöting, N., & Vollmar, B. (2018) · Journal of Advanced Research · doi:10.1016/j.jare.2018.11.003 · Cited by 11
Yu, W., Zhao, J., Li, W., Zheng, Y.-P., Zhu, J., Liu, J., Liu, R., Wang, Z., Wang, X., & Hai, C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117274 · Cited by 11
Deciphering metabolic reprogramming of immune cells within the tumor microenvironment
Wang, Y., Chen, W., Wang, Z., Cai, S., Zhao, X., Jin, J., Gao, T., & Qu, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07069-y · Cited by 13
“Sustained high levels of ROS generated by neutrophils can induce DNA damage and immune suppression, thereby leading to tumor development [35, 36].”
Implications of protein ubiquitination modulated by lncRNAs in gastrointestinal cancers
Zhou, J., Liu, J., Xing, H., Shen, Y., Xie, M., Chai, J., & Yang, M. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114558 · Cited by 10
Wu, P., Quan, H., Kang, J., He, J., Luo, S., Xie, C., Xu, J., Tang, Y., & Zhao, S. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504017x14886420642823 · Cited by 10
Zhu, Q., Wu, X., Ma, L., & Xue, H. (2022) · Disease Markers · doi:10.1155/2022/4596810 · Cited by 10
Sirbu, D., Luli, S., Leslie, J., Oakley, F., & Benniston, A. C. (2019) · ChemMedChem · doi:10.1002/cmdc.201900181 · Cited by 9
Self-citationChen, W., Zhang, Q., Ding, M., Yao, J., Guo, Y., Yan, W., Yu, S., Shen, Q., Huang, M., Zheng, Y., et al. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109847 · Cited by 10
Zhu, Q., Chai, Y., Jin, L., Ma, Y., Lü, H., Chen, Y., & Wei, F. (2023) · Scientific Reports · doi:10.1038/s41598-023-45289-8 · Cited by 13
“…in cancer progression and metastasis, via direct effects on cancer cells 10,12,22,23 , remodeling of the ECM 24,25 , stimulation of angiogenesis 16,26 , activation of protumorigenic macrophages 27 , inhibition of antitumor immunity 16,28 , production of ROS 10,26,29 , or release of NETs 14,30–32 .”
BackgroundYang, K., Ryu, T., & Chung, B. S. (2023) · Antioxidants · doi:10.3390/antiox12040841 · Cited by 10
“Manifestations of ALD include fatty liver, liver inflammation, hepatic fibrosis, cirrhosis, and hepatocellular carcinoma (HCC).”
BackgroundSupercharged eGFP-TRAIL Decorated NETs to Ensnare and Kill Disseminated Tumor Cells
Cao, T. M., & King, M. R. (2020) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-020-00639-8 · Cited by 8
Aging induces changes in cancer formation and microbial content in a murine model of bladder cancer
Woolbright, B. L., Xuan, H. M., Ahmed, I., Rajendran, G., Abbott, E., Dennis, K. L., Zhong, C., Umar, S., & Taylor, J. A. (2024) · GeroScience · doi:10.1007/s11357-024-01064-9 · Cited by 6
Engineered Nanomaterials for Tumor Immune Microenvironment Modulation in Cancer Immunotherapy
Xing, H., & Li, X. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202400425 · Cited by 8
Cui, C., Barberi, T. J., Suresh, R., & Friedman, A. D. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12904 · Cited by 7
Feng, L., Bai, K., He, L., Wang, H., & Zhang, W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1585895 · Cited by 7
Okimoto, S., Tashiro, H., Iwako, H., Kuroda, S., Kobayashi, T., Hinoi, T., & Ohdan, H. (2020) · Hepatology Research · doi:10.1111/hepr.13558 · Cited by 4
Rennert, C., Lang‐Meli, J., Gromak, M., Hofmann, M., Thimme, R., & Roehlen, N. (2022) · Liver Cancer International · doi:10.1002/lci2.70 · Cited by 3
Pham, D.-T., & Tran, T.-D. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108888 · Cited by 3
Bachmann, M., Lamprecht, L., Gonther, S., Pfeilschifter, J. M., & Mühl, H. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15649 · Cited by 3
Liu, Y., Deng, M., Wang, Y., Wang, H., Li, C., & Wu, H. (2020) · Oncology Letters · doi:10.3892/ol.2020.11493 · Cited by 3
“Phosphorylated RPN2 activates the signal transducer and activator of STAT3 and is also responsible for the RPN2-stimulated elevated expression of MMP-9 and for invading HCC cells (62).”
Cellular senescence during aging and chronic liver diseases
Jurk, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00005-5 · Cited by 2
Self-citationYu, H., Yan, X., Chen, G., Li, R., Yang, Z., Liang, Z., Ye, L., Chen, Y., & Li, Y. (2024) · Biomolecules and Biomedicine · doi:10.17305/bb.2024.10103 · Cited by 3
“These mice received an intraperitoneal injection of 30 mg kg − 1 N-nitrosodiethylamine (DEN) (Cat: N0258, Sigma Aldrich, USA) [20].”
MethodZhang, X., Fan, H., Zhang, X., Wang, Y., & Chen, G. (2025) · Health Science Reports · doi:10.1002/hsr2.70405 · Cited by 2
Myokines as a Factor of Physiological Inflammation
Zakharova, A. N., Милованова, К. Г., Krivoshchekov, S. G., & Капилевич, Л. В. (2024) · Human Physiology · doi:10.1134/s0362119724701019 · Cited by 2
Exposomal determinants of non-genetic plasticity in tumor initiation
Carra, D., Maas, S. C. E., Seoane, J. A., & Alonso‐Curbelo, D. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.01.010 · Cited by 2
Sun, J., Yang, F., Li, Y., Li, S., & Song, J. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218527 · Cited by 3
Fan, W., Zhou, F., Song, Q., Liu, L., Huang, S., Pan, J., Zhang, Y., Yang, Q., Pan, M., & Zhang, Y. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121984 · Cited by 2
Role of the ubiquitin ligase KPC1 in NF-κB activation and tumor suppression
Kravtsova‐Ivantsiv, Y., Kwon, Y. T., & Ciechanover, A. J. (2016) · Journal of Analytical Science & Technology · doi:10.1186/s40543-016-0087-4 · Cited by 1
“This repression prevents development of neutrophil-driven hepatocellular carcinoma (Wilson et al., 2015).”
BackgroundWu, Y., Xiao, Y., Tian, L., He, B., Liu, J., Li, Z., Yang, H., Chen, Y., Luo, Q., Li, B., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02630-9 · Cited by 3
“hTERT complexed with p50 homodimers regulates PLEKHA7 expression Previous research reported that the suppressive effects of p50 on gene expression are mediated by p50 homodimers [36].”
BackgroundMethodThorne, A. J., Gao, A., Necker‐Brown, A., Bansal, A., Kalyanaraman, K., Chandramohan, P., Sasse, S. K., Gerber, A. N., Mostafa, M., & Newton, R. (2025) · Molecular Pharmacology · doi:10.1016/j.molpha.2025.100073 · Cited by 1
Exploring circulating biomarkers in patients with hepatocellular cancer
Ogle, L. F. (2017)
Roles of the Immune System in the Development and Progression of Hepatocellular Carcinoma
Maurício, J., Reeves, H. L., & Wilson, C. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-92216-4_3
Self-citation陈, 琛. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2022.132168
Role of Transcription Factor NF-κB in Neuroimmunoendocrine Mechanisms of Respiratory Diseases
Belova, Y. I., Mironova, E. S., Zubareva, T. S., Kvetnoy, I. M., & Yablonsky, P. K. (2024) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093024020285
Therapeutic potential of kakkatin derivatives against hepatocellular carcinoma
Chahal, S., & Patial, V. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i3.101686
Zhang, R. Y., & Zhao, J. J. (2025) · Clinical Rheumatology · doi:10.1007/s10067-025-07596-5
“Additionally, NFKB1 encodes the monomeric subunit p50 and its precursor protein p105 [52]. p50 can inhibit inflammation by preventing the NF-κB dimer from binding to the κB sites on target gene promoters and further enhances this inhibition by recruiting co-repressors [53].”
In vivo CRISPR screening links NFKB1 to endocrine resistance in ER+ breast cancer
Lyu, C., Hall, S., Stamnes, M. A., & Chen, S. (2026) · Endocrine Related Cancer · doi:10.1530/erc-25-0463
Wu, X., Wang, X., Yuan, Y., Qi, K., Xie, Z., Yin, H., Wu, J., & Zhang, S. (2025) · Environmental Chemistry and Ecotoxicology · doi:10.1016/j.enceco.2025.08.014
UTP3: A Prognostic Marker in Hepatocellular Carcinoma and Its Role in Immunity and Epigenetics
Xu, Y., Zhang, S., Wei, G., Lv, Y., Dai, L., Li, C., & Wang, M. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70632
Wang, X., Li, X., Wu, Y., Hong, J., & Zhang, M. (2023) · Figshare · doi:10.6084/m9.figshare.22599587
Wang, X., Li, X., Wu, Y., Hong, J., & Zhang, M. (2023) · Figshare · doi:10.6084/m9.figshare.22599593
Wang, X., Li, X., Wu, Y., Hong, J., & Zhang, M. (2023) · Figshare · doi:10.6084/m9.figshare.22599596
Wang, X., Li, X., Wu, Y., Hong, J., & Zhang, M. (2023) · Figshare · doi:10.6084/m9.figshare.22599581
Wang, X., Li, X., Wu, Y., Hong, J., & Zhang, M. (2023) · Figshare · doi:10.6084/m9.figshare.22599590
Wang, X., Li, X., Wu, Y., Hong, J., & Zhang, M. (2023) · Figshare · doi:10.6084/m9.figshare.22599578
Wang, X., Li, X., Wu, Y., Hong, J., & Zhang, M. (2023) · Figshare · doi:10.6084/m9.figshare.22599584
Wang, X., Li, X., Wu, Y., Hong, J., & Zhang, M. (2023) · Figshare · doi:10.6084/m9.figshare.22599599
Coopération oncogénique et effets métaboliques de FGF19 dans le carcinome hépatocellulaire
Bedoya, J. U. (2021) · theses.fr (ABES) · doi:10.70675/d2df913bz04e7z457dzb21dzf6ae23303e0c
Targeting the cell cycle : A novel therapeutic strategy against ATIP3- deficient breast cancer
Haykal, M. M. (2023) · theses.fr (ABES) · doi:10.70675/03dee32bz395cz469ez9a0dzf4c5f2e84330
Metadata
- Authors
- Wilson, C. L., Jurk, D., Fullard, N., Banks, P., Page, A., Luli, S., Elsharkawy, A. M., Gieling, R. G., Chakraborty, J. B., Fox, C., Richardson, C., Callaghan, K., Blair, G. E., Fox, N., Lagnado, A., Passos, J. F., Moore, A. J., Smith, G. R., Tiniakos, D. G., Mann, J., Oakley, F., & Mann, D. A.
- Affiliations
- Newcastle University (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University of Manchester (GB)
- Hammersmith Hospital (GB)
- University of Leeds (GB)
- Corresponding author
- Oakley, F.
- Mann, D. A.
- ORCID
- Venue
- Nature Communications
- Published
- 2015-04-16
- Volume
- 6
- Issue
- 1
- Pages
- 6818-6818
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4410629
- OpenAlex
- W2107718568
- Cited by
- 171
- References
- 58
- Citations by year
- 2026: 3 · 2025: 12 · 2024: 14 · 2023: 24 · 2022: 23 · 2021: 21 · 2020: 20 · 2019: 7 · 2018: 19 · 2017: 12 · 2016: 13 · 2015: 3
- FWCI
- 7.71
- Type
- journal article
- Language
- en
- Update notices
- correction (2015-09-21)
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, cc-by)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Northumbria Research Link (Northumbria University) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Wellcome Trust (G0900535, WT086755MA, 087961)
- Cancer Research UK
- Newcastle University
- European Commission (223151)
- University of Adelaide
- Medical Research Council (G0900535, MR/K006312/1, MR/K0019494/1, M501700, G0700890, MR/K001949/1)
- Biotechnology and Biological Sciences Research Council (BB/K017314/1, BB/H022384/1)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- NFKB1, hepatocellular carcinoma, neutrophils, tumor microenvironment, HDAC1, S100A8/S100A9, CXCL1, CXCL2, neutrophil chemokines, reactive oxygen species, chronic liver disease, aging, diethylnitrosamine, tumour suppressor, neutrophil depletion
- MeSH terms
- Alkylating Agents, Animals, Diethylnitrosamine, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Experimental, Mutation, Neutrophils, Mice, Knockout, Calgranulin A, Calgranulin B, Mice, NF-kappa B p50 Subunit, Chemokine CXCL1, Chemokine CXCL2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.